Description

Ba-D-Erythro-Pentofuranoside, Ethyl 2,3-Dideoxy-3-[(2R)-2-Hydroxypropyl]- (9Ci) is a specialized carbohydrate derivative and nucleoside analog intermediate of significant interest in advanced organic synthesis. This compound matters for its role as a key chiral building block in the development of novel pharmaceuticals and bioactive molecules, particularly antiviral and anticancer agents. It is primarily needed by research institutions, pharmaceutical R&D laboratories, and fine chemical manufacturers focused on nucleoside chemistry and prodrug development.

Application

• Pharmaceutical Intermediate: Critical chiral synthon for the research and development of novel nucleoside-based antiviral and anticancer drugs.
• Prodrug Synthesis: Used in the design and synthesis of prodrugs to enhance the bioavailability and targeting of active pharmaceutical ingredients (APIs).
• Glycochemistry Research: Serves as a valuable substrate in glycosylation studies and the synthesis of complex carbohydrate analogs.
• Bioconjugation: Employed in the modification of biomolecules, linking active agents to carriers or targeting moieties.
• Chemical Biology Probes: Utilized in the creation of molecular probes to study enzymatic processes and biological pathways involving nucleosides.
• Process Chemistry: Acts as a starting material or intermediate in scale-up processes for active pharmaceutical ingredient (API) manufacturing under GMP conditions.

Basic Information

Product Name	Ba-D-Erythro-Pentofuranoside, Ethyl 2,3-Dideoxy-3-[(2R)-2-Hydroxypropyl]- (9Ci)
CAS No.	305847-23-8
Molecular Formula	C10H18O5
Molecular Weight	218.25 g/mol
Synonyms	Ethyl 2,3-dideoxy-3-[(2R)-2-hydroxypropyl]-β-D-erythro-pentofuranoside; 305847-23-8; β-D-Erythro-Pentofuranoside, ethyl 2,3-dideoxy-3-[(2R)-2-hydroxypropyl]-; Ethyl 3-[(2R)-2-hydroxypropyl]-2,3-dideoxy-β-D-erythro-pentofuranoside
EINECS	Contact for details

Quality Control

Our Ba-D-Erythro-Pentofuranoside, Ethyl 2,3-Dideoxy-3-[(2R)-2-Hydroxypropyl]- (9Ci) is produced under strict quality management systems. Each batch undergoes rigorous analytical testing, including chiral purity verification and impurity profiling by HPLC, to ensure it meets the high standards required for pharmaceutical research and development. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and specific tests is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption. For long-term storage, consider using desiccants or an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 97.0%
Chiral Purity	≥ 99.0% ee
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.